with vascular endothelial growth factor were deposited onto the outer surface of the scaffold and cultured for a further 7 days. After this, endothelial cell outgrowth from within the channels into the collagen gel was observed, showing that the engineered vasculature maintains its capacity for angiogenesis. Furthermore, the HDMECs appeared to have formed perfusable tubules within the gel. These results show promising steps towards the development of an in vitro platform for studying angiogenesis and vascular biology in a tissue engineering context. 
Introduction
There has been significant progress in the field of tissue engineering over recent years. However, one of the current obstacles blocking major clinical translation is the production of thick ( ≥ 2 mm), complex tissues due to the lack of rapid neovascularization of the constructs [Griffith et al., 2005] . Blood vessel formation is tightly regulated and relies on the chronologically precise adjustment of vessel growth, maturation and suppression of endothelial cell (EC) growth -all of which are controlled by a large number of factors that influence each other [Carmeliet and Jain, 2011] . To induce vascularization within tissueengineered (TE) substitutes, these same processes need to occur; it is therefore not surprising that this remains a challenge in the tissue engineering field.
The most promising approaches to circumvent slow revascularization of TE constructs have historically used the body as an in vivo bioreactor, making use of the omentum and, in some cases, arteriovenous shunts. For example, Baumert et al. [2007] and Saxena et al. [2010] used the omentum and the body as an in vivo bioreactor for the tissue engineering of the bladder and cardiac tissue, respectively. Baumert et al. [2007] used pig urothelial cells and smooth-muscle cells seeded into sphere-shaped, small-intestinal submucosa matrix grafts transferred into the omentum in the pig after 3 weeks. Three weeks later, at harvest, these were found to be highly vascularized, and the authors concluded that the omentum permitted the in vivo maturation of these seeded scaffolds with the development of a dense vasculature, which they anticipate prevents fibrosis and loss of contractility. Saxena et al. [2010] implanted their TE constructs -ovine oesophageal epithelial cells implanted on collagen sheets preseeded with fibroblasts to form a rudimentary tubularized oesophagus into the sheep omentum -and demonstrated vascular coverage and ingrowth into the periphery of the construct.
An alternative approach is that of using an arteriovenous shunt. Birla et al. [2005] achieved vascularization for neonatal cardiac myocytes placed in silicone chambers close to a vascular pedicle. Kneser et al. [2006] used an arteriovenous loop in a rat model to overcome the problem of engineering larger-volume bone tissues. This approach of using an arteriovenous shunt was considered in a review of the challenges of angiogenesis and tissue engineering by Laschke et al. [2006] . These authors concluded, however, that future directions should focus on the creation of microvascular networks within 3-dimensional (3D) tissue constructs in vitro prior to implantation. We have also recently reviewed this area [Dew et al., 2015] and conclude that progress remains slow in neovascularization of TE constructs because there are very few systems which allow one to study perfusion conditions, cell type and scaffold architecture -all of which are important for neovascularization. We suggest it is therefore important to take a step back and understand how these factors work together to promote angiogenesis in order to advance this crucial area.
Clinically, the study of angiogenesis has increased rapidly over the last 40 years as a result of its major role in a number of pathologies including cancer, rheumatoid arthritis and retinopathy, to name but a few [Carmeliet, 2000] . Assays have been developed in an attempt to study the process. Ideally, these would enable the assessment of multiple factors, providing reliable and reproducible results directly relating to those found in the clinic [Staton et al., 2009] . From the observations gleaned from tissue engineering strategies, this would include the combination of a relevant vascular architecture and the ability to incorporate the relevant cell combinations, along with flow conditions and appropriate extracellular matrix (ECM) components. There is currently no single 'gold standard' assay that provides a useful platform to incorporate all of these elements in an in vitro setting.
We have developed a novel 4-step technique to produce an in vitro angiogenesis model via the combination of electrospinning and robocasting methods used widely in the tissue engineering field [Ortega et al., 2015] . Using the combination of these 2 approaches offers a range of advantages in the design of angiogenesis assays. For instance, the use of robocasting allows for the tuning of the vascular network geometry in terms of size, thickness and morphology, enabling bespoke designs to be tested rapidly and scaled-up easily where necessary. The use of electrospun fibres provides high levels of porosity and surface area to enable diffusion and facilitate cell attachment, respectively [Ashammakhi et al., 2008] . In addition, electrospinning also offers the ability to easily spin different polymers, allowing for the control of degradation times [Blackwood et al., 2008] and mechanical properties, whilst enabling the combination of different membrane combinations, as recently reported by our group [Bye et al., 2013] . Synthetic pseudovascular networks produced via this methodology provide a surface that supports EC adhesion [Ellis-Behnke et al., 2006; Beachley and Wen, 2010; Bye et al., 2013] and could provide the ability to test a range of angiogenic growth factors, combine multiple cell combinations and study the effects of perfusion through interconnected afferent and efferent channels. In this study, we firstly describe the recellularization of such scaffolds using both HDMECs and HDFs in different combinations. We then describe the use of these scaffolds to observe the outgrowth of 3D tubular structures into a vascular endothelial growth factor (VEGF)-loaded collagen gel.
Materials and Methods

Production of Synthetic Pseudovascular Nets
Synthetic pseudovascular nets were produced via a 4-step technique using a combination of electrospinning and robocasting as previously published [Ortega et al., 2015] . Briefly, electrospun mats were produced by dissolving medical-grade poly-3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV; Goodfellow) in a mixture of dichloromethane and methanol. An optimal concentration of 10% w/w of PHBV (containing 10% w/w of methanol) was prepared and electrospun. Alginate was robocast onto the PHBV electrospun mat with the purpose of acting as a sacrificial template. An alginate paste was placed inside a syringe barrel attached to a dispensing system (Ultra 2800, EFD Inc., East Providence, R.I., USA) whilst a 3D printer (RepRap Mendel, Oldbury on Severn, UK) was used to hold the dispensing arm and print the alginate. The electrospinning process was then repeated to cover the alginate sacrificial template with a nanofibrous PHBV layer. To remove the alginate and achieve the creation of a hollow network between the 2 electrospun mats, the scaffolds were submerged in 0.5 M of EDTA solution overnight on a gel-shaker set to 70 r.p.m.
The overall dimensions of these nets as shown in figure 1 were 2 × 4 cm with tubes that were approximately 0.5 mm wide with a flat bottom and curved ceiling with a height of 0.15 mm [Ortega et al., 2015] . The hexagonal section of the scaffold measured approximately 5 × 7.5 mm at the widest points.
Cells and Cell Culture
Proliferating HDMECs from juvenile foreskin (Promocell, Heidelberg, Germany) were grown in gelatin-coated 0.1% (w/v) pig-skin gelatin in PBS T25 tissue culture flasks. Cells were grown in EC growth medium MV containing 0.05 ml/ml FCS, 0.004 ml/ ml EC growth supplement, 10 ng/ml epidermal growth factor (recombinant human), 90 μg/ml heparin, 1 μg/ml hydrocortisone, 100 U/ml penicillin, 0.1 mg/ml streptomycin and 0.25 μg/ml amphotericin B. The medium was replenished every 2-3 days. HDMECs were passaged when they reached approximately 80% confluence, split using a ratio of 1: 3 and used at passage 5 in this study. HDFs were cultured from skin samples taken from consenting patients undergoing elective abdominoplasty or breast reduction surgery, as described previously [Bye et al., 2014] and were used according to the requirements stipulated by the Research Tissue Bank Licence 12179. HDFs were cultured in DMEM supplemented with FCS 10% (v/v), streptomycin (0.1 mg/ml), penicillin (100 IU/ml) and amphotericin B (0.5 g/ml) and were used at passages 6-8.
Endothelialization of Synthetic Pseudovascular Nets
Prior to cell culture, scaffolds were sterilized by immersion into 70% ethanol (v/v in distilled water) for 30 min, followed by washing with sterile PBS. Scaffolds were then cannulated with a 24-gauge cannula (BD Insyte TM ) under a dissection microscope (Wild M3Z, Heerbrugg, Switzerland). In this study, varying cell combinations were seeded onto and within the synthetic scaffolds. These included HDMECs seeded into the channels, a combination of HDMECs and HDFs seeded within the channels and, finally, HDMECs seeded within the channels and HDFs seeded on the outside surface of the channels. To ensure that cells attached uniformly to the artificial channels, seeding was performed using a 2-stage process. First, 0.5 × 10 6 HDMECs (per scaffold) were resuspended in 0.25 ml of EC growth medium MV. Using a 1-ml syringe, the cell suspension was injected into the scaffold through the cannula, submerged in media and kept overnight in an incubator at 37 ° C and 5% CO 2 . The constructs were then turned over and a second suspension of 0.5 × 10 6 HDMECs was seeded and left overnight. For the introduction of HDFs into the channels, HDMECs were firstly allowed to attach to the scaffolds for a minimum of 3 h before injecting 0.5 × 10 6 HDFs and then repeating this process following the second injection of HDMECs. For the introduction of HDFs onto the outside surface of the channels, a b 5 mm Fig. 1. a The appearance of one of the pseudovascular nets which had the overall dimensions of 2 × 4 cm. b The pseudovascular net is designed to be cannulated with a needle and perfused (for a detailed description of the production of the pseudovascular net, see Ortega et al. [2015] 322 0.5 × 10 6 HDFs were pipetted over the outer surface of the scaffolds immediately after the seeding of the HDMECs. The scaffolds were placed in an incubator for up to 2 h at 37 ° C and 5% CO 2 without being submerged in media to allow attachment of the HDFs. The scaffolds were then subsequently submerged in media overnight before repeating the process.
Outgrowth of ECs from Biodegradable Scaffolds into an ECM
Scaffolds that had been recellularized and cultured at 37 ° C and 5% CO 2 for 7 days were taken, and the channels were pierced with a sterile, 21-gauge hypodermic needle (Terumo, MediSupplies, Bournemouth, UK) to introduce small holes into the scaffold to allow cell migration out of the scaffold. Collagen gels (2 mg/ml) were prepared by adding 200 μl of rat-tail type I collagen (collagen-I; 3 mg/ml, Gibco/Life Technologies, Paisley, UK) to 100 μl of concentrated MEM solution (Gibco) and VEGF to a final concentration of 10 ng/ml. The collagen solution (approx. 50 μl) was then pipetted into the wells formed by the channels and allowed to set at 37 ° C for 15 min. The scaffolds were then submerged in medium and cultured for a further 7 days, changing the medium every 3 days.
Immunohistochemistry
Samples were fixed for 2 h in 4% paraformaldehyde (w/v) in HBSS with Ca 2+ and Mg 2+ before dehydrating with graded alcohol washes and embedding in paraffin wax. Next, 6-μm sections were cut and mounted on slides and stained with haematoxylin and eosin (HE; Sigma-Aldrich).
Immunofluorescence Staining
Immunofluorescence staining was performed as described previously [Correa de Sampaio et al., 2012] . Briefly, samples were fixed in 4% paraformaldehyde (w/v) in HBSS with Ca 2+ and Mg 2+ for 30 min. Samples were then quenched with 100 m M glycine, washed once with PBS and then blocked for 1 h with 1% (w/v) bovine serum albumin (BSA) in PBS at room temperature. Separate samples were then incubated with mouse monoclonal anti-human CD31 (1: 20) in 1% (w/v) BSA (DAKO, UK) and mouse monoclonal anti-human VE-cadherin (CD144; 1: 50) in 1% (w/v) BSA (BD Biosciences) at room temperature overnight. The scaffolds were subsequently washed for 2 h in 1% BSA (w/v) in PBS with 0.1% Tween (v/v), followed by incubation with Alexa Fluor TM 546 nm goat anti-mouse secondary antibody (1: 200) in 1% (w/v) BSA (Life Technologies) for 2 h at room temperature before counterstaining with the nuclear stain DAPI (1: 1,000) in 1% (w/v) BSA. Finally, the scaffolds were washed with 1% BSA (w/v) in PBS with 1% Tween (v/v) for at least 8 h. After this, the samples were imaged using a Zeiss LSM 510 confocal microscope (Zeiss, UK) to observe cellular organization.
Perfusion with FITC-Lectin
To visualize potential vessel formation, the scaffolds were perfused with 100 μl of FITC-labelled tomato lectin (Vector Laboratories) at a rate of 40 μl/min, controlled using a syringe pump (Genie Plus, Kent Scientific, Torrington, Conn., USA).The scaffolds were then fixed in 4% paraformaldehyde (w/v) in HBSS with Ca 2+ and Mg 2+ for 30 min and subsequently immunostained for CD31 as described above.
Results
The Formation of a Continuous EC Monolayer within the Pseudovascular Net Lumen Requires the Support of Fibroblasts
In order for the electrospun pseudovascular net ( fig. 1 a) to act as a model vascular structure that can support neovascularization within biological structures, optimization of seeding and growth of an endothelial monolayer within the scaffold lumen was performed. Initially, HDMECs were injected (by perfusing the nets by inserting a syringe; fig. 1 b) at a high density within the lumen alone, and allowed to adhere to the upper and lower surfaces. After 7 days of culture, cell coverage was investigated using HE staining of the pseudovascular net in cross section ( fig. 2 ) . Although HDMECs could be detected, coverage was not continuous ( fig. 2 a-c) . Mesenchymal cells, including pericytes and fibroblasts, have been shown to support endothelial function in in vitro models, mimicking perivascular cells [Kirkpatrick et al., 2011] . To determine if HDFs can augment HDMEC adhesion and survival within the pseudovascular net, HDFs were first seeded within the lumen with the HDMECs, as in other vascular models this can result in a self-organizing system replicating endothelial-pericyte architecture [KunzSchughart et al., 2006; Hurley et al., 2010] . This resulted in continuous cellular coverage of the inside of the lumen ( fig. 2 d-f ). As some of the signalling pathways known to regulate endothelial barrier function are also soluble growth factors, we also seeded HDFs on the outside of the pseudovascular net and HDMECs on the inside of the lumen, physically separating the cells. On HE staining, increased cell coverage of the lumen was seen, although this did not appear as continuous as the seeding of both HDMECs and HDFs within the lumen ( fig. 2 g-i) .
To further characterize the EC coverage within the lumen of the pseudovascular net, the net was sectioned to reveal the upper, curved surface and the lower, flat surface before the staining with CD31 and DAPI and the confocal imaging. In nets seeded with HDMECs alone, CD31 staining lacked continuity and the ECs had a rounded appearance, with little to no evidence of CD31 at cell-cell junctions, especially on the curved surface ( fig. 3 a, b) . Although HE staining showed a continuous cell layer with both HDFs and HDMECs seeded within the lumen, the CD31 staining did not show continuous endothelial coverage. However, unlike surfaces with ECs alone, patches of confluent ECs were observed with discernable cell-cell junction staining of CD31 that appeared to be partially detracted from the HDFs cells on the pseudovascular net, suggesting poor adhesion ( fig. 3 c, d ). In contrast, the combination of HDFs on the external surface and HDMECs on the internal surface generated a continuous endothelial monolayer with a characteristic 'cobblestone' appearance and clear cell-cell junction staining of CD31, particularly on the curved surface ( fig. 3 e, fig. 4 a, b) .
ECs Maintain the Capacity to Migrate out of the Pseudovascular Net to Form New Perfusable Vascular Structures within a Biological Matrix
After establishing that HDMECs could form a continuous monolayer of cells within the lumen of the pseudovascular net, we next aimed to determine if these had the capacity to form new vascular structures within a biological matrix, as this would be required if the artificial vascular structure is to have the ability to integrate with engineered tissues or biological material in the future. Initial studies indicated that HDMECs would not be able to degrade the electrospun mat or invade it in a timely manner for this to occur. Accordingly, the pseudovascular net was punctured, providing discreet exit points for the HDMECs. The well-shaped region within the hexagon pattern of the net was then filled with collagen-I gel containing VEGF to promote migration of the ECs from within the net into the gel ( fig. 5 a) . After 7 days of culture, a CD31-positive network was found extending throughout this collagen-I gel with the appearance of a crude vascular network ( fig. 5 b) , and surrounded by HDFs that had also migrated into the gel.
We then aimed to determine if the new vasculature could be perfused via the pseudovascular net by injection of FITC-lectin, commonly used in vivo to investigate vascular function [Thurston et al., 1998; Ezaki et al., 2001; Mazzetti et al., 2004] . Confocal imaging showed a significant overlap between CD31 and FITC-lectin, indicating that perfusion had occurred ( fig. 5 c) . It is important to note that these experiments were repeated 5 times with at least 6 replicates per experiment, and vessel formation was found in around 50% of the samples.
These structures generated in the pseudovascular nets were apparently random and looked more like large sinusoid/lymphoid structures than blood vessels. In width, they ranged from 10 μm up to structures which, at their widest, were closer to 80 μm. There was no obvious pattern. They extended partially throughout the collagen/ VEGF gel (spanning approx. 1 cm from the peripheral vascular channel in all directions) over the 7 days of culture.
Discussion
The aim of this study was to develop a controllable 3D in vitro model of vascular structures to study the factors affecting angiogenesis and vascular biology. The ultimate aim of this work is to translate the use of such vascular networks to the clinic in order to assist in the 'take' of TE materials that lack intrinsic vasculature.
For many years, it has been recognized that, while it is possible to produce human 3D TE constructs in the laboratory, unless they are very thin epithelial structures, they can be lost upon transplantation due to delays in neovascularization [Griffith et al., 2005] . Introducing a vascular network into a TE construct is a major challenge which only a few groups are tackling. In an attempt to understand the fundamental principles behind the induction of angiogenesis, development of 3D models investigating the interactions between different cell types has progressed [Mon- , 1993; Donovan et al., 2001; Santos et al., 2008] . Other studies have looked at the influence of fluid flow on EC survival and sprouting [Moll et al., 2013; VukadinovicNikolic et al., 2014] . However, we are unaware of any models that have the ability to combine different cell combinations and fluid flow to investigate the induction of earlystage blood vessel formation for TE applications. This work represents a significant step towards this goal. Our aim was to develop a simple synthetic pseudovascular network which could be recellularized to form an interconnected monolayer of ECs. A promising or successful structure was viewed as one which could demonstrate evidence of new vessel formation, sprouting outwardly from these re-endothelialized channels. The main finding of this study was the production of tubular architecture emerging from the pseudovasculature in response to the proangiogenic mitogen VEGF. HDMECs exit the pseudovascular net to form a perfusable network within VEGFA-loaded collagen-I gels. a The diagram shows the process of making holes in a pseudovascular net that has been preseeded internally with HDMECs, and externally with HDFs. After 7 days of culture, holes are made on the inner side of the net's artificial vascular channels facing into the hexagonal well using a 21-gauge needle. The hexagonal area is then filled with collagen-I gel containing VEGFA, and allowed to set before submerging in medium for a further 7 days to allow the growth of cells from the net into the collagen gel. b 3D confocal projection of CD31-positive structures within the collagen-I gel from the centre of the hexagonal well. c Confocal images of nuclei (blue), FITClectin (green) and CD31 (red) and merged image of all 3 channels of the collagen-I gel within the centre of the hexagonal well after perfusion of the pseudovascular net with FITC-lectin.
This study shows that lining the synthetic vasculature with HDMECs was not very successful when these cells were introduced on their own. Their ability to adhere and form a continuous lining was much improved by the addition of HDFs, particularly when added to the outer layer of the synthetic channels. In summary, endothelial cover was relatively poor with HDMECs alone, better with the inclusion of HDFs inside the lumen together with HDMECs, but best of all with the HDMECs inside and HDFs outside the lumen. In other recent studies, we showed that fibroblasts themselves are not able to penetrate through a nanofibrous PHBV electrospun layer, even after 2 weeks of culture [Bye et al., 2013 [Bye et al., , 2014 .
Accordingly, we speculate that this arrangement, i.e. HDMECs inside the channels with HDFs outside, provides the opportunity for cross-talk and the 'reassurance' of the HDMECs by the fibroblasts, as found in other studies [Dietrich and Lelkes, 2006; Kunz-Schughart et al., 2006; Hughes, 2008; Kirkpatrick et al., 2011] . It is likely that both are producing soluble and ECM factors; however, this was not investigated in this particular study.
After the successful re-endothelialization of the synthetic channels, we were keen to explore whether new vessels would sprout from these channels in response to proangiogenic stimuli, the criterion that had been originally selected as the definition of a successful system. Results showed that placing VEGF-loaded collagen gels onto the scaffolds caused HDMEC outgrowth to occur from within the channels into the collagen gel, showing that the engineered vasculature maintained its capacity for angiogenesis. Furthermore, the HDMECs appeared to have formed perfusable tubules (determined by connecting these nets to a syringe pump and perfusing at 40 μl/ min) within the gel. However, these tubules did not look like 'normal' blood vessels and were arguably closer to angiomas. There are many studies that show that VEGF on its own will direct the migration of ECs, but this commonly results in the formation of large and leaky vessels [Jain and Munn, 2000; Thurston, 2002; Tomanek, 2002] . It is suspected that this was the case in this particular study. It is also important to note that these results were found in around 50% of the experiments, highlighting the need for further optimization. However, we emphasize that this is, to the best of our knowledge, the first demonstration of endothelial tubule formation in 3D from a synthetic vascular network. The rate of perfusion and detailed flow effects were not examined in this study (perfusion was at a fixed rate of 40 μl/min in the experiments), but this should now be possible using these synthetic pseudovascular networks. Similarly, we do not know what role the added fibroblasts play in the formation of these structures.
In summary, we previously reported the production of an EC-lined synthetic pseudovascular network [Ortega et al., 2015] . This study has taken this work a significant step further, by showing the production of perfusable tubular sprouts emanating from the HDMEC-lined networks in response to the proangiogenic mitogen VEGF. This system will now lend itself to investigations of perfusion flow and the response of the cells to combinations of angiogenic mitogens and also the examination of the nature of the cross-talk between the HDMECs and HDFs. It will also be important to examine the response to these cellseeded constructs implanted in an animal model in the future. Overall, these results indicate promising steps towards the development of an in vitro platform for studying angiogenesis and vascular biology for a range of applications.
